… " no-reflow may be … no-reflow) and monastral blue (to delineate the risk region) and the
hearts were removed, sectioned, and observed under UV light. We found the extent of no-reflow …

… The incidence of no-reflow associated with balloon dilatation in the optimized PSBD group
(… can help reduce the incidence of no-reflow associated with balloon dilatation, effectively …

… treatment of STEMI. The absence of adequate myocardial perfusion after percutaneous
coronary intervention is defined as no-reflow [… reperfusion strategies, no-reflow is still developing …

… Moreover, early detection of no-reflow is crucial since the results … treatment of no-reflow
and preventative measures [6]. Therefore, we sought to evaluate a direct assessment of no-reflow …

… The primary endpoint in our study was the incidence of no-reflow, … No reflow is lower with
epinephrine than verapamil (25% vs … in managing patients with no-reflow during PPCIs. Further …

… been studied for no-reflow treatment, including intracoronary … treatment of no-reflow.
Aim of work: evaluating epinephrine and glycoprotein IIb/IIIa inhibitors efficacy in treating no-reflow …

… Factors independently associated with slow/no-reflow post-PCI were preprocedure systolic
… predictor for no-reflow after SVG-PCI. Factors associated with MACEs and the slow/no-reflow …

… Nicorandil has been administered in treating NRP in patients after PCI in some studies, and
it may improve the symptoms of no-reflow in patient. [13] However, there is still a lack of high …

… The no-reflow (NR) phenomenon is frequently encountered in acute coronary syndrome.
We evaluated the association between anticoagulation and risk factors in atrial fibrillation (…

… Our aim in this study is to determine the frequency of no-reflow phenomenon in COVID-19
patients with STEMI and to determine the factors that predict this complication. …